AR113027A2 - PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER - Google Patents
PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERInfo
- Publication number
- AR113027A2 AR113027A2 ARP180102713A ARP180102713A AR113027A2 AR 113027 A2 AR113027 A2 AR 113027A2 AR P180102713 A ARP180102713 A AR P180102713A AR P180102713 A ARP180102713 A AR P180102713A AR 113027 A2 AR113027 A2 AR 113027A2
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- cancer
- supports
- various types
- peptide combinations
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a péptidos, proteínas, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, la presente se refiere a la inmunoterapia contra el cáncer. Se refiere asimismo a epítopos peptídicos para linfocitos T asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que, por ejemplo, pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antitumorales, o a estimular ex vivo linfocitos T que después serán transferidos a los pacientes. Los péptidos unidos a moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tales, también pueden ser dianas de anticuerpos, de receptores de linfocitos T solubles, y de otras moléculas de unión.This refers to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, this is concerned with immunotherapy against cancer. It also refers to peptide epitopes for tumor-associated T lymphocytes, alone or in combination with other tumor-associated peptides, which, for example, can serve as active pharmaceutical ingredients in vaccine compositions intended to stimulate antitumor immune responses, or to stimulate T lymphocytes ex vivo. which will then be transferred to the patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides as such, can also be targets of antibodies, soluble T cell receptors, and other binding molecules.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211276P | 2015-08-28 | 2015-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR113027A2 true AR113027A2 (en) | 2020-01-15 |
Family
ID=60451268
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102632A AR105851A1 (en) | 2015-08-28 | 2016-08-29 | PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP180102713A AR113027A2 (en) | 2015-08-28 | 2018-09-21 | PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101475A AR122218A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101474A AR122217A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102632A AR105851A1 (en) | 2015-08-28 | 2016-08-29 | PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101475A AR122218A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101474A AR122217A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Country Status (2)
| Country | Link |
|---|---|
| AR (4) | AR105851A1 (en) |
| MA (2) | MA43091A1 (en) |
-
2016
- 2016-08-26 MA MA43091A patent/MA43091A1/en unknown
- 2016-08-26 MA MA42022A patent/MA42022A1/en unknown
- 2016-08-29 AR ARP160102632A patent/AR105851A1/en unknown
-
2018
- 2018-09-21 AR ARP180102713A patent/AR113027A2/en unknown
-
2021
- 2021-05-31 AR ARP210101475A patent/AR122218A2/en unknown
- 2021-05-31 AR ARP210101474A patent/AR122217A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR122218A2 (en) | 2022-08-24 |
| MA43091A1 (en) | 2019-08-30 |
| AR105851A1 (en) | 2017-11-15 |
| MA42022A1 (en) | 2018-07-31 |
| AR122217A2 (en) | 2022-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023001346A1 (en) | Use of peptides in immunotherapy against small cell lung cancer and others. | |
| CL2018000780A1 (en) | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other types of cancer | |
| CO2018002202A2 (en) | Peptides and combinations of peptides for immunotherapy against prostate cancer and other types of cancer | |
| CO2018008763A2 (en) | Peptides, combinations of peptides and cells for use in immunotherapy against urinary bladder cancer and other types of cancer | |
| CO2018003860A2 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other types of cancer | |
| CR20180245A (en) | NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TYPES OF CANCER | |
| CO2018010284A2 (en) | Treatments against uterine cancer | |
| CO2017008902A2 (en) | Peptides and new combinations of peptides for immunotherapy against lung cancer, including amicrocytic lung cancer and other types of cancer | |
| CR20180423A (en) | NEW PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER (Divisional 2018-0174) | |
| CR20180051A (en) | NEW CELLULAR EPITHOPES AND NEW COMBINATIONS OF CELLULAR EPITHOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER TYPES OF CANCER. | |
| CO2017012891A2 (en) | Peptides and combinations of peptides for immunotherapy against ovarian cancer and other types of cancer | |
| CR20180001A (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER TYPES OF CANCER. | |
| CO2018000245A2 (en) | Peptides and combinations of peptides for immunotherapy against pancreatic cancer and other types of cancer | |
| CO2019012077A2 (en) | Peptides and combinations thereof for use in immunotherapy against various types of cancer | |
| CO2018012914A2 (en) | Peptides and combination of peptides as targets and for immunotherapy against gallbladder cancer and cholangiocarcinoma, as well as other types of cancer | |
| CL2018000545A1 (en) | New peptides, combinations of peptides and supports for use in the immunotherapeutic treatment of various types of cancer. | |
| CO2018004869A2 (en) | Peptides and combination of peptides for immunotherapy against various types of cancer | |
| CL2023001324A1 (en) | Peptides, combinations, cells for immunotherapy against bladder cancer and other cancers | |
| CO2018012294A2 (en) | Immunotherapy against melanoma and other types of cancer | |
| CL2020002935A1 (en) | Peptides for use in cancer immunotherapy | |
| CL2021001010A1 (en) | Peptides and peptide combinations for use in immunotherapy against small cell lung cancer and other types of cancer (divisional application no. 201800780) | |
| CO2017009101A2 (en) | Peptides and peptide combination | |
| CO2018000247A2 (en) | New cell epitopes and new combinations of cell epitopes for use in the immunotherapy of myeloma and other types of cancer | |
| CO2017010830A2 (en) | Peptides and combinations of peptides and supports | |
| AR113027A2 (en) | PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |